The PAX6-ZEB2 axis promotes metastasis by mediating E-cadherin downregulation through the PI3K/AKT signaling pathway, thereby mediating cell migration, stem cell transformation, and cisplatin resistance, ultimately affecting survival in NSCLC patients (Fig. 6j). Here, AKT1 is linked to non-small cell lung carcinoma.